Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 11 | 2024 | 214 | 2.620 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2018 | 33 | 0.950 |
Why?
|
| Nutritionists | 2 | 2024 | 4 | 0.930 |
Why?
|
| Diet, Gluten-Free | 6 | 2024 | 58 | 0.920 |
Why?
|
| Bone Density | 2 | 2018 | 209 | 0.880 |
Why?
|
| Dietetics | 1 | 2022 | 3 | 0.870 |
Why?
|
| Digestive System Diseases | 1 | 2022 | 18 | 0.850 |
Why?
|
| Gastroenterology | 1 | 2022 | 144 | 0.720 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 151 | 0.590 |
Why?
|
| Eosinophilic Esophagitis | 4 | 2017 | 18 | 0.550 |
Why?
|
| Nutritional Status | 2 | 2022 | 80 | 0.530 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 105 | 0.510 |
Why?
|
| Child | 18 | 2024 | 7174 | 0.500 |
Why?
|
| Glutens | 3 | 2024 | 83 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2018 | 560 | 0.340 |
Why?
|
| Transglutaminases | 1 | 2009 | 40 | 0.340 |
Why?
|
| Antibodies | 1 | 2009 | 353 | 0.290 |
Why?
|
| Patient Compliance | 2 | 2024 | 231 | 0.270 |
Why?
|
| Eosinophilia | 3 | 2015 | 84 | 0.260 |
Why?
|
| Body Mass Index | 1 | 2009 | 773 | 0.250 |
Why?
|
| Child, Preschool | 9 | 2024 | 3731 | 0.240 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 20 | 0.240 |
Why?
|
| Esophagitis | 3 | 2010 | 43 | 0.230 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 99 | 0.230 |
Why?
|
| Adolescent | 10 | 2024 | 9263 | 0.230 |
Why?
|
| North America | 1 | 2022 | 184 | 0.210 |
Why?
|
| Pennsylvania | 2 | 2018 | 95 | 0.190 |
Why?
|
| Humans | 22 | 2024 | 89356 | 0.180 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9057 | 0.170 |
Why?
|
| Prevalence | 2 | 2024 | 1243 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 345 | 0.160 |
Why?
|
| Food Hypersensitivity | 2 | 2017 | 71 | 0.150 |
Why?
|
| Microbiota | 1 | 2023 | 402 | 0.150 |
Why?
|
| Esophageal Stenosis | 1 | 2017 | 26 | 0.140 |
Why?
|
| Crohn Disease | 1 | 2023 | 762 | 0.140 |
Why?
|
| Hashimoto Disease | 1 | 2016 | 11 | 0.140 |
Why?
|
| Graves Disease | 1 | 2016 | 36 | 0.130 |
Why?
|
| Budesonide | 1 | 2016 | 46 | 0.130 |
Why?
|
| Hyperthyroidism | 1 | 2016 | 75 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2015 | 31 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 773 | 0.120 |
Why?
|
| Rhinitis, Allergic | 1 | 2015 | 45 | 0.120 |
Why?
|
| Female | 12 | 2024 | 46202 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 2017 | 339 | 0.120 |
Why?
|
| Male | 11 | 2024 | 42411 | 0.120 |
Why?
|
| Infant | 5 | 2024 | 3160 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2016 | 241 | 0.120 |
Why?
|
| Eosinophils | 2 | 2015 | 194 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 3666 | 0.110 |
Why?
|
| Prognosis | 2 | 2018 | 3783 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2018 | 2872 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 1840 | 0.090 |
Why?
|
| Disease Progression | 1 | 2015 | 1489 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2010 | 109 | 0.090 |
Why?
|
| Risk Factors | 3 | 2024 | 5499 | 0.090 |
Why?
|
| Anthropometry | 1 | 2009 | 75 | 0.080 |
Why?
|
| Duodenum | 1 | 2009 | 103 | 0.080 |
Why?
|
| Body Height | 1 | 2009 | 100 | 0.080 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 805 | 0.080 |
Why?
|
| Body Weight | 1 | 2009 | 452 | 0.070 |
Why?
|
| Child Health Services | 2 | 2017 | 48 | 0.070 |
Why?
|
| Cromolyn Sodium | 1 | 2005 | 3 | 0.070 |
Why?
|
| Cytokines | 1 | 2010 | 803 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2005 | 64 | 0.070 |
Why?
|
| Androstadienes | 1 | 2005 | 72 | 0.060 |
Why?
|
| Esophagus | 2 | 2016 | 106 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1213 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1862 | 0.060 |
Why?
|
| Drug Approval | 1 | 2024 | 66 | 0.050 |
Why?
|
| Enteral Nutrition | 1 | 2023 | 102 | 0.050 |
Why?
|
| Biopsy | 3 | 2016 | 1184 | 0.050 |
Why?
|
| Forecasting | 1 | 2024 | 306 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2024 | 2485 | 0.050 |
Why?
|
| Gastrointestinal Agents | 1 | 2024 | 172 | 0.050 |
Why?
|
| Child Development | 1 | 2023 | 167 | 0.050 |
Why?
|
| Remission Induction | 1 | 2023 | 740 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2002 | 261 | 0.050 |
Why?
|
| Food Supply | 1 | 2021 | 29 | 0.050 |
Why?
|
| Seasons | 2 | 2015 | 237 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2016 | 682 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 838 | 0.040 |
Why?
|
| Bacteria | 1 | 2023 | 478 | 0.040 |
Why?
|
| Community Networks | 1 | 2018 | 30 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 164 | 0.040 |
Why?
|
| Colorado | 1 | 2017 | 37 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1365 | 0.040 |
Why?
|
| Health Promotion | 1 | 2018 | 165 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2017 | 90 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2016 | 10 | 0.030 |
Why?
|
| Honey | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sweetening Agents | 1 | 2016 | 17 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2002 | 580 | 0.030 |
Why?
|
| Sucrose | 1 | 2016 | 65 | 0.030 |
Why?
|
| Fruit | 1 | 2016 | 76 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1714 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 4289 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2018 | 351 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 856 | 0.030 |
Why?
|
| Allergens | 1 | 2015 | 183 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1595 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 26607 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1870 | 0.030 |
Why?
|
| United States | 1 | 2024 | 6989 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2010 | 128 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2009 | 68 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2009 | 138 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 266 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 119 | 0.020 |
Why?
|
| Asthma | 1 | 2015 | 978 | 0.020 |
Why?
|
| Vomiting | 1 | 2009 | 195 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2009 | 122 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 6312 | 0.020 |
Why?
|
| Fluticasone | 1 | 2005 | 30 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1066 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2005 | 157 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1597 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 135 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1671 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 374 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 2401 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 8241 | 0.010 |
Why?
|